全文获取类型
收费全文 | 329篇 |
免费 | 25篇 |
国内免费 | 13篇 |
专业分类
儿科学 | 29篇 |
妇产科学 | 2篇 |
基础医学 | 30篇 |
口腔科学 | 4篇 |
临床医学 | 36篇 |
内科学 | 78篇 |
皮肤病学 | 7篇 |
神经病学 | 8篇 |
特种医学 | 84篇 |
外科学 | 23篇 |
综合类 | 10篇 |
预防医学 | 12篇 |
眼科学 | 1篇 |
药学 | 17篇 |
肿瘤学 | 26篇 |
出版年
2024年 | 1篇 |
2022年 | 2篇 |
2021年 | 6篇 |
2020年 | 1篇 |
2019年 | 1篇 |
2018年 | 1篇 |
2017年 | 1篇 |
2016年 | 7篇 |
2015年 | 6篇 |
2014年 | 11篇 |
2013年 | 9篇 |
2012年 | 2篇 |
2011年 | 4篇 |
2010年 | 7篇 |
2009年 | 10篇 |
2008年 | 7篇 |
2007年 | 17篇 |
2006年 | 6篇 |
2005年 | 9篇 |
2004年 | 4篇 |
2003年 | 8篇 |
2002年 | 4篇 |
2001年 | 1篇 |
2000年 | 7篇 |
1999年 | 13篇 |
1998年 | 25篇 |
1997年 | 21篇 |
1996年 | 25篇 |
1995年 | 24篇 |
1994年 | 14篇 |
1993年 | 11篇 |
1992年 | 10篇 |
1991年 | 5篇 |
1990年 | 4篇 |
1989年 | 11篇 |
1988年 | 12篇 |
1987年 | 10篇 |
1986年 | 9篇 |
1985年 | 9篇 |
1984年 | 4篇 |
1983年 | 5篇 |
1982年 | 4篇 |
1981年 | 3篇 |
1980年 | 5篇 |
1979年 | 3篇 |
1978年 | 2篇 |
1976年 | 4篇 |
1975年 | 2篇 |
排序方式: 共有367条查询结果,搜索用时 0 毫秒
21.
22.
Infusible platelet membrane microvesicles: a potential transfusion substitute for platelets 总被引:8,自引:0,他引:8
FC Chao ; BK Kim ; AM Houranieh ; FH Liang ; MW Konrad ; SN Swisher ; JL Tullis 《Transfusion》1996,36(6):536-542
BACKGROUND: Several substitutes for intact, viable platelets have been used for transfusion, both to people and in animal models, with varied success. Infusible platelet membrane (IPM) is prepared from human platelets. IPM retains the glycoprotein (GP)lb receptor and has platelet factor 3 activity (procoagulant activity). However, factor V, serotonin, a cytoplasmic marker enzyme (purine nucleotide phosphorylase), GPIIb/IIIa complex, and HLA class I and II antigens are all absent in IPM. STUDY DESIGN AND METHODS: IPM is prepared from outdated platelets. The platelets were disrupted by freezing and thawing; they were washed and heated to inactivate possible viral contaminants, and then the sonicated membrane microvesicle fraction was separated and lyophilized. The hemostatic activity of IPM was measured by its ability to reduce the prolonged bleeding time in thrombocytopenic rabbits. RESULTS: Administration of IPM at a dose of 2 mg per kg results in a substantial reduction in the bleeding time. In a series of 23 experiments, a median preinjection bleeding time of 15 minutes was reduced to 6 minutes within 4 hours after IPM administration. Administration of IPM did show a mild enhancement in the thrombogenicity index, as measured in the Wessler rabbit model. This enhancement is, however, not significant, as a thrombogenicity index value of up to 0.6 is clinically acceptable. CONCLUSION: IPM may have clinical potential as a substitute for platelets in the treatment of bleeding due to thrombocytopenia. 相似文献
23.
目的:观测研究下坡(离心)运动对大鼠骨骼肌肌浆网Ca2+-ATP酶活性,Ca2+摄取与释放在量与时程上的影响。此外,测定离子载体的刺激作用,即测定在含与不含(Ca2+离子载体)A23187时Ca2+-ATP酶活性的比值,用以评定囊泡的完整性。方法:成年雄性SD大鼠随机分为对照与离心运动组, 离心运动的大鼠分别于运动后即刻, 4, 24, 48, 72 和144h后取样 (n=7). 离心运动方式采用90min持续跑台下坡运动(-16°;15m/min)。取大鼠红股肌制备组织匀浆, 测定肌浆网Ca2+-ATP酶活性,Ca2+摄取与释放。结果:与对照组[19.25±1.38 nmol ·min-1·(mg protein)-1]相比, 肌浆网Ca2+摄取分别于运动后即刻和4h下降了29% and 36% (P<0.05), 24h依然降低(P<0.05). 肌浆网Ca2+释放与对照组[31.06±2.36 nmol·min-1·(mg protein)-1] 相比,也分别于运动后即刻和4h下降了37% and 39% (P<0.05), 24h持续降低(P<0.05). 用含离子载体测定的肌浆网Ca2+-ATP酶活性运动后4h降低了31%(P<0.05), 并于运动后24h仍然降低 (P<0.05)。运动后, 含与不含A23187时测定的Ca2+-ATP酶活性的比值未见显著性改变, 表明该运动没有明显改变肌浆网膜的完整性。结论:一次性低强度,长时间下坡运动导致肌浆网功能长时间降低, 运动后恢复期两天尚未完全恢复, 亦可构成离心运动诱导的骨骼肌某些功能降低的基础。提示这些变化可能产生于离心收缩时肌节长度不匀一性所造成的张力应激。 相似文献
24.
目的:目前颅骨修补材料有很多种,但都为异源性无机骨替代物,并且应用该方法又要给患者再次行开颅手术,实验拟开展新型颅骨再生材料的研究。方法:实验于2006-05/11在解放军第一五七医院动物中心及中山大学附属第三医院动物实验室完成。①实验动物:30只犬随机分为实验组20只,对照组10只。②实验方法:应用纳米级羟基磷灰石为支架和成骨细胞培养,加入脱矿的犬类骨基质为载体的重组人类骨形成蛋白2,制成复合软质再生颅骨。实验组犬在右侧颅骨缺损中填补藻酸钙凝胶、成骨细胞、纳米级骨粉的复合材料,左侧颅骨缺损中填补藻酸钙凝胶、成骨细胞、纳米级骨粉和重组人类骨形成蛋白2的复合材料。对照组犬在右侧为单纯颅骨缺损,左侧颅骨缺损中填补藻酸钙凝胶、成骨细胞、纳米级骨粉和重组人类骨形成蛋白2复合材料。实验过程中对动物处置符合动物伦理学标准。③实验评估:手术后1,2,3,6个月X射线片检查颅骨缺损修复情况,对再生的颅骨组织标本进行茜素红S染色,观察成骨能力及再生材料骨膜组织细胞体外培养情况。结果:实验动物均进入结果分析。术后1个月,成骨活跃,骨端新生骨小梁基本覆盖骨断端,缺损区可见较多新生骨小梁形成,骨端新生骨小梁向缺损区长入;术后2个月可见较多散在骨岛形成;术后3个月可见成熟骨,并有髓腔形成,缺损区大量新骨形成。而各对照组骨断端处有散在骨岛,或被增生的纤维结缔组织占据,可见大量纤维组织及毛细血管长入,植入的基质材料基本被吸收,无新骨生成。结论:应用纳米级羟基磷灰石为支架和成骨细胞培养,加入脱矿骨基质为载体的重组人类骨形成蛋白2,制成的复合软质再生颅骨能自身代谢并逐渐骨化,形成新的颅骨。 相似文献
25.
W. Tacke M.D. S. Paech M.D. W. Kruis M.D. H. Stuetzer Ph.D. J. M. Mueller M.D. D. J. Ziegenhagen M.D. E. Zehnter M.D. 《Diseases of the colon and rectum》1993,36(4):377-382
The results of different treatment modalities in 196 patients with rectal carcinoma were analyzed. Patients were treated by palliative endoscopic laser therapy (n=37), palliative surgery (n=42), and curative surgery (n=117). Laser therapy was successful for recanalization of the stenosis with 1.3 (range, one to five) sessions. Bleeding stopped always after a single session. If necessary, treatment was repeated monthly. Good results were seen in 35/37 patients (95 percent). They received an average of four sessions during their remaining lifetime, the median of which was eight months. No morbidity and no therapy-related mortality occurred. Palliative surgery (expanded and restricted resections) showed good results in 41/42 patients (98 percent). Morbidity was 3/42 (7 percent); mortality was 1/42 (2 percent). The median survival was 14 months for local surgical treatment and 6.3 months for deep anterior rectal resection and for abdominoperineal (Dixon's) resection. No significant difference (
P
=0.15) in survival times between the palliatively treated patient groups could be detected. Survival prognosis was determined by tumor stage and outcome. In the curative (outcome R0) resection patients, morbidity and mortality were each 9/117 (8 percent). The threeyear survival rate was 80 percent. If curative resection is impossible, laser therapy should be considered as an alternative to palliative surgery because of less hospitalization and seemingly less side effects. The decision on the kind of palliation in patients with rectal carcinoma should be made with regard to the patient's quality of life. 相似文献
26.
S Dold MW Laschke S Lavasani MD Menger B Jeppsson H Thorlacius 《British journal of pharmacology》2009,156(3):466-474
Background:
Bile duct obstruction is associated with hepatic accumulation of leukocytes and liver injury. The aim of this study was to evaluate the effect of simvastatin on cholestasis-induced liver inflammation and tissue damage.Experimental approach:
C57BL/6 mice were treated with simvastatin (0.02 and 0.2 mg·kg−1) and vehicle before and after undergoing bile duct ligation (BDL) for 12 h. Leukocyte recruitment and microvascular perfusion in the liver were analysed using intravital fluorescence microscopy. CXC chemokines in the liver were determined by enzyme-linked immunosorbent assay. Liver damage was monitored by measuring serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Hepatic levels of myeloperoxidase (MPO) were also determined.Key results:
Administration of 0.2 mg·kg−1 simvastatin decreased ALT and AST by 87% and 83%, respectively, in BDL mice. This dose of simvastatin reduced hepatic formation of CXC chemokines by 37–82% and restored sinusoidal perfusion in cholestatic animals. Moreover, BDL-induced leukocyte adhesion in sinusoids and postsinusoidal venules, as well as MPO levels in the liver, was significantly reduced by simvastatin. Notably, administration of 0.2 mg·kg−1 simvastatin 2 h after BDL induction also decreased cholestatic liver injury and inflammation.Conclusions and implications:
These findings show that simvastatin protects against BDL-induced liver injury. The hepatoprotective effect of simvastatin is mediated, at least in part, by reduced formation of CXC chemokines and leukocyte recruitment. Thus, our novel data suggest that the use of statins may be an effective strategy to protect against the hepatic injury associated with obstructive jaundice. 相似文献27.
28.
29.
Greenlee MW; Koessler M; Cornelissen FW; Mergner T 《Cerebral cortex (New York, N.Y. : 1991)》1997,7(3):253-267
Visual discrimination and short-term recognition memory for computer-
generated random patterns were explored in 23 patients with a postsurgical
lesion in one of the cortical hemispheres. Their results are compared with
those of 23 age-matched volunteers. In a same- different forced-choice
discrimination task, d' and log beta (measures of sensitivity and bias), as
well as reaction time (RT) were determined. All participants viewed
patterns defined either by luminance contrast or isoluminant red-green
color contrast, the amplitude of which was adjusted to be 10 times the
respective detection threshold level. Block patterns consisting of a 6 x 6
matrix of light and dark (red and green) checks were randomly configured on
each presentation. They were presented in pairs, randomly in two visual
quadrants for a duration of 200 msec. Three presentation conditions were
used: simultaneous presentation of reference and test stimulus, sequential
presentation with a short delay (interstimulus interval, ISI = 3 s), and
sequential presentation with a long delay (ISI = 6 s). The results indicate
that patients with a lesion in the occipitotemporal cortex, the superior
temporal cortex and the frontal cortex were significantly impaired on both
luminance-contrast and color-contrast pattern discrimination. Patients with
damage in the anterior inferotemporal cortex showed no overall impairment.
The results suggest that performance in visual discrimination and
recognition memory tasks rely on distributed neural processes with more
than one neocortical location.
相似文献
30.
Susanne JJ Claessen Johanna MW Hazes Margriet AM Huisman Derkjen van Zeben Jolanda J Luime Angelique EAM Weel 《BMC musculoskeletal disorders》2009,10(1):71